Today news
About the same in other media
AstraZeneca sells $2.2bn of Covid vaccine in first nine months
Reading now: 343
AstraZeneca has sold more than $2.2bn (£1.64bn) of its Covid-19 vaccine in the first nine months of this year, as the drugmaker said it is set to move to “modest profitability” as new orders are received.
Britain’s biggest drugmaker has so far promised to provide the jab, which it developed with Oxford University, on a not-for-profit basis through the pandemic.
“The company is now expecting to progressively transition the vaccine to modest profitability,” it said in a trading update. “Covid‑19 vaccine sales in the fourth quarter are expected to be a blend of the original pandemic agreements and new orders, with the large majority coming from pandemic agreements.”
Earlier this week the Anglo-Swedish drugmaker confirmed it would create a
Read more on theguardian.comAbout this in other media
Germany reports first suspected case of Omicron COVID-19 variant euronews.com /2 years ago
A new Covid variant is no surprise when rich countries are hoarding vaccines theguardian.com /2 years ago
EU's COVID travel pass will expire nine months after last vaccine dose, says Brussels euronews.com /2 years ago
Show more
The website finance-news.co. is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
